OTHER INFORMATION
−Removed: None of our directors or officers informed us of the adop tion or termi nation of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Item 408 of Regulation S-K, during the three-month period ended June 30, 2025.
−Removed: Agreement and Plan of Merger by and among Merit Medical Systems, Inc., Biolife Transaction Sub, LLC, Biolife, L.L.C., and Shareholder Representative Services LLC, dated as of May 16, 2025.
+Added: None of our directors or officers informed us of the adop tion or termi nation of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Item 408 of Regulation S-K, during the three-month period ended September 30, 2025.
Second Amended and Restated Articles of Incorporation.*
Fourth Amended and Restated Bylaws.*
−Removed: Form of Restricted Stock Unit Award Agreement, dated May 15, 2025, by and between Merit Medical Systems, Inc.
−Removed: and each of the following individuals:
−Removed: Carpenter, Stephen C.
−Removed: Evans, David K.
−Removed: Floyd, Thomas J.
−Removed: Gunderson, Laura S.
−Removed: Kaiser, Michael R.
−Removed: McDonnell, F.
−Removed: Ann Millner, Silvia M.
−Removed: Perez and Lynne N.
−Removed: Corporate Policy on Insider Trading (revised May 15, 2025).
+Added: Chief Executive Officer Employment Agreement, dated October 3, 2025, by and between Merit Medical Systems, Inc.
+Added: and Martha G.
+Added: Performance Stock Unit Award Agreement (Three Year Performance Period), dated October 3, 2025, by and between Merit Medical Systems, Inc.
+Added: and Martha G.
+Added: Restricted Stock Unit Award Agreement, dated October 3, 2025, by and between Merit Medical Systems, Inc.
+Added: and Martha G.
+Added: CEO Transition Agreement, dated October 3, 2025, by and between Merit Medical Systems, Inc.
+Added: Lampropoulos.
+Added: Employment Agreement, dated September 1, 2025, by and between Merit Medical Systems, Inc.
+Added: and Christian Adam Smith.
+Added: Indemnification Agreement, dated September 1, 2025, by and between Merit Medical Systems, Inc.
+Added: and Christian Adam Smith.
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 .
2 unchanged sentences
Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 .
−Removed: The following financial information from the quarterly report on Form 10-Q for the quarter ended June 30, 2025, formatted in Inline Extensible Business Reporting Language (iXBRL):
+Added: The following financial information from the quarterly report on Form 10-Q for the quarter ended September 30, 2025, formatted in Inline Extensible Business Reporting Language (iXBRL):
(i) Consolidated Balance Sheets, (ii) Consolidated Statements of Income, (iii) Consolidated Statements of Comprehensive Income (iv) Consolidated Statements of Stockholders’ Equity, (v) Consolidated Statements of Cash Flows, and (vi) related Condensed Notes to the Unaudited Consolidated Financial Statements, tagged in detail.
4 unchanged sentences
MERIT MEDICAL SYSTEMS, INC.
−Removed: July 30, 2025
+Added: October 30, 2025
+Added: /s/ MARTHA G.
Chief Executive Officer and President
−Removed: July 30, 2025
+Added: October 30, 2025
/s/ RAUL PARRA
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.